Table 2 Patient characteristics
From: Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014
| Â | Men | Women | All |
|---|---|---|---|
% | 75.6 | 24.4 | 100.0 |
Age [25–75 % percentile] | 72 [64–79] | 73 [65–81] | 72 [64–79] |
Morphology | |||
 Non-inv pap trans carcinoma low-grade | 43.4 | 43.0 | 43.4 |
 Non-inv pap trans carcinoma high-grade | 7.6 | 5.6 | 7.1 |
 Displasia | 3.9 | 4.1 | 3.9 |
 Carcinoma in situ | 3.7 | 3.1 | 3.6 |
 Inv trans carcinoma | 41.3 | 44.3 | 42.0 |
Stage | |||
 Localised | 91.5 | 89.9 | 91.1 |
 Regional advanced | 5.6 | 5.9 | 5.7 |
 Distant advanced | 2.9 | 4.1 | 3.2 |
Death | |||
 Bladder cancer | 15.0 | 17.2 | 15.5 |
 Other cancer | 22.1 | 21.4 | 22.0 |
 Other than cancer | 30.2 | 26.2 | 29.1 |
 Unknown | 2.7 | 2.6 | 2.8 |
 Alive | 30.0 | 32.6 | 30.6 |